Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05415501 · ClinicalTrials.gov registry record · NA

Sentence Production Training in Aphasia

A NA study of Aphasia, sponsored by Purdue University.

Recruiting
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT05415501 is a NA study of Aphasia that is actively recruiting participants, run by Purdue University. The registered enrollment target is 104 participants, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05415501, a NA study of Aphasia, is actively recruiting participants, sponsored by Purdue University.

RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

This project focuses on developing a novel treatment for sentence production and comprehension in aphasia, using implicit priming. First set of experiments will aim examine which learning conditions are most effective in creating maximal training gains. Then, in a later study, the investigators will develop and test the efficacy of a novel treatment study based on findings from the first set of the studies.

Conditions Studied

Interventions

  • BEHAVIORAL Sentence training

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2021-08-01
Est. Completion 2026-05-30
Phase NA

Sponsor

Purdue University

141 total trials

What the Registry Record Tells You About NCT05415501

The ClinicalTrials.gov registry entry for NCT05415501 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (28% higher). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Sentence training is the first listed.

NCT05415501 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05415501 about?

NCT05415501 is a clinical study titled "Sentence Production Training in Aphasia". This project focuses on developing a novel treatment for sentence production and comprehension in aphasia, using implicit priming. First set of experiments will aim examine which learning conditions are most effective in creating maximal training gains. Then, in a later study, the investigators will...

What is the current status of trial NCT05415501?

This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2021-08-01. Estimated completion is 2026-05-30.

What conditions does trial NCT05415501 study?

This clinical trial studies the following conditions: Aphasia.

What interventions are being tested in trial NCT05415501?

The interventions under investigation include: Sentence training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05415501?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05415501 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.